Skip to main content
. 2014 Feb 28;7(5):1639–1644. doi: 10.3892/ol.2014.1923

Table III.

p33ING1b promoter methylation in fecal DNA of CRC and AA patients and the control group.

p33ING1b methylation, n (%)

Fecal DNA Samples, n Methylated Unmethylated
CRCa 61 45 (73.77) 16 (26.23)
AAa 27 17 (62.96) 10 (37.04)
Control 20 1 (5.00) 19 (95.00)
a

P<0.01, vs. control group.

AA, advanced adenoma; CRC, colorectal cancer; p33ING1B, p33 inhibitor of growth 1b.